Implantable Spinal-Devices Are a Multi-billion Dollar Industry and
the Leaders In the Industry Are Medtronic, St. Jude Medical, and Boston
Scientific by Spinal Stimulator Off Label Use Whistleblower Lawyer
Implantable Neurostimulation Systems and other spinal-devices are a huge
business for the medical implant device industry. The global market
for spinal-devices is currently over $ 3 billion per year and is
expected to increase to over $5 billion per year by 2018. Currently,
the major manufacturers in the neurostimulator market are
Medtronic, St. Jude
Medical, and Boston Scientific.
Neurostimulators have been used for a variety
of types of chronic back pain situations including heriniated disks,
postlaminectomy paid, Complex Reginal Pay Syndrome, unsuccessful disk
surgery, Degenerative Disk Disease, and Failed Back Syndrome. The
Medtronic implantable neurostimulation system is indicated for spinal
cord stimulation (SCS)
as an aid in the management of chronic, intractable pain of the trunk
and/or limbs—including unilateral or bilateral pain associated with
several different conditions. Unfortunately, because of the profits to
be made from implanting a spinal stimulator, many people have received
spinal stimulators for off-label or non-approved indications.
Medical professionals that are aware of significant off-label use of
spinal stimulators are encouraged to properly report any Medicare fraud
or Medicaid fraud that may be occurring. Further, through a whistleblower qui tam action, these whistleblowers can receive large financial rewards for being the first to expose Medicare fraud or Medicaid fraud. Please feel free to go to the
following web page for information on Qui Tam Whistleblower Reward Lawsuits and Reporting Medicare Fraud.
